Vyvanse vs Adderall: Onset, Duration and Key Differences

Vyvanse and Adderall are the two names that come up most often when Americans talk about ADHD medication. They are often discussed as rivals, as if one were the good one and the other the bad one.

The truth is less dramatic. Both are amphetamine medications. What separates them is mostly the route: how the amphetamine is packaged, how fast it reaches your bloodstream and how long it stays there.

A note before we start. Neither Vyvanse nor Adderall is sold in Turkey, where I live, so I have never taken either one. This is a research-based explainer built from the FDA prescribing information for each drug and from published studies. It is not a personal review, and it is not advice about which one you should take.

The short version

If you only read one paragraph, read this one.

Vyvanse contains lisdexamfetamine, a prodrug. It does nothing until your body converts it into dextroamphetamine, which happens mostly in the blood. Adderall contains four amphetamine salts that are active as soon as they are absorbed. Immediate-release Adderall is a tablet taken more than once a day; Adderall XR is a capsule designed to cover the day with one dose.

Both are Schedule II controlled substances. Both carry the same FDA boxed warning about abuse, misuse and addiction. Both now have generic versions. And no major analysis has crowned one of them the winner.

Vyvanse: a prodrug that waits for your blood

Lisdexamfetamine is dextroamphetamine with an amino acid, l-lysine, chemically attached to it. In that bound form, the molecule is inactive.

After you swallow it, it is absorbed and then split apart, according to the FDA label, "primarily in blood due to the hydrolytic activity of red blood cells." What is left is dextroamphetamine, the active part, and l-lysine, which the body treats like any other amino acid. The label also notes that lisdexamfetamine is not processed by the liver's cytochrome P450 enzymes.

That conversion step is the whole story of Vyvanse. Because your red blood cells release the active drug at their own pace, dextroamphetamine levels climb gradually rather than all at once. You cannot speed this up by taking the capsule differently, which matters for the misuse question later.

Vyvanse comes as capsules and as chewable tablets. The label allows the capsule to be opened and the contents mixed into yogurt, water or orange juice, which helps people who struggle to swallow pills. It is approved for ADHD in adults and children 6 and older, and for moderate to severe binge eating disorder in adults. The label states plainly that it is not for weight loss.

Adderall: four amphetamine salts in one pill

Its label describes Adderall as a single amphetamine product made of mixed salts. It contains equal amounts by weight of four salts: dextroamphetamine sulfate, dextroamphetamine saccharate, amphetamine sulfate and amphetamine aspartate monohydrate.

The result is a mix of two mirror-image forms of amphetamine, dextroamphetamine and levoamphetamine, in roughly a 3 to 1 ratio. That is one real chemical difference from Vyvanse, which delivers only dextroamphetamine.

Adderall comes in two main forms:

• Adderall (immediate-release tablets). Approved for ADHD and for narcolepsy. The label says the first dose is taken on waking, with one or two more doses spaced 4 to 6 hours apart. It is not recommended for children under 3.
• Adderall XR (extended-release capsules). Approved for ADHD in adults and children 6 and older. Each capsule holds two kinds of beads: one releases right away, the other is delayed. The capsule can be opened and sprinkled on applesauce.

I go deeper into the drug itself in the explainer on what Adderall is.

Side by side

Here is how the two compare on the points people search for most. Everything in this table comes from the current FDA labels.

	Vyvanse	Adderall IR	Adderall XR
Active ingredient	Lisdexamfetamine (prodrug)	Four amphetamine salts	Four amphetamine salts
What reaches the brain	Dextroamphetamine only	Dextro- and levoamphetamine, about 3 to 1	Dextro- and levoamphetamine, about 3 to 1
How release is controlled	Conversion by red blood cells	None, tablet releases at once	Immediate and delayed beads
Time to peak blood level	About 3.5 to 4 hours for dextroamphetamine (fasted)	About 3 hours	About 7 hours
Typical daily schedule	Once daily, in the morning	Up to three times daily	Once daily, in the morning
Duration noted in label studies	Adult study measured benefit from 2 to 14 hours	Doses spaced 4 to 6 hours apart	One capsule matched two IR doses taken 4 hours apart
Approved uses	ADHD (age 6+), binge eating disorder (adults)	ADHD, narcolepsy	ADHD (age 6+)
Forms	Capsule, chewable tablet	Tablet	Capsule
Can be opened or mixed	Capsule into yogurt, water or orange juice	Not applicable	Beads on applesauce
DEA schedule	Schedule II	Schedule II	Schedule II
Generic available	Yes, since 2023	Yes	Yes

A word on the "time to peak" row. Peak blood level is not the same as the moment you feel something. It is a pharmacology measurement, and food shifts it. For Vyvanse, a high-fat meal pushed the dextroamphetamine peak back by about an hour. For Adderall XR, a high-fat meal delayed it by about two and a half hours. Neither meal changed how much drug was absorbed overall.

Onset and duration: what the labels actually measured

The difference people notice most is how the day unfolds.

Immediate-release Adderall is the shortest of the three. Its label describes repeat doses 4 to 6 hours apart, which tells you roughly how long one tablet is expected to cover. Some people like that flexibility: an afternoon dose can be skipped on a quiet day. Others find the ups and downs tiring.

Adderall XR packs two doses into one capsule. The label shows that a single XR capsule produced blood levels comparable to two immediate-release tablets taken four hours apart. Its peak comes later, around 7 hours.

Vyvanse builds slowly because of the conversion step. In the adult study described in its label, people with ADHD did a timed math test at several points after their dose. Vyvanse beat placebo at every time point measured, from 2 hours to 14 hours after the dose. That is a long window, and it explains why many people choose it to cover work plus evening tasks.

Long is not always good, though. A drug that is still active late in the day can collide with sleep, which I wrote about in ADHD medication and insomnia. And how quickly any stimulant kicks in varies from person to person.

Misuse potential: lower is not zero

This is where the prodrug design matters most, and where online claims get exaggerated.

Because Vyvanse needs red blood cells to become active, taking it by another route does not skip the conversion step. In a small study of injected doses, dextroamphetamine from lisdexamfetamine took about two and a half hours to peak, compared with under an hour for injected dextroamphetamine (Jasinski & Krishnan, 2009, intravenous study). A second controlled study looked at swallowed doses. Jasinski and Krishnan (2009) gave single oral doses to 36 adults with a history of stimulant abuse. At an amount of amphetamine equivalent to 40 mg of immediate-release dextroamphetamine, Vyvanse produced significantly lower drug liking scores. But at a dose 50 percent higher, the liking scores were similar to dextroamphetamine.

The Vyvanse label reports the intravenous findings too: injected lisdexamfetamine produced more liking than placebo, though less than an equivalent dose of injected dextroamphetamine.

So the honest summary is this. The prodrug design appears to blunt misuse, especially by routes other than swallowing. It does not remove it. The FDA treats both drugs the same way: both are Schedule II, and both carry an identical boxed warning about abuse, misuse and addiction.

That class-wide warning was strengthened in 2023. In its safety communication, the FDA reported that most people who misuse prescription stimulants get them from family members or friends, usually for free. Its estimate was 56 to 80 percent. Whatever you are prescribed, keeping it locked up and never sharing it does more for safety than the choice between brands.

If the bigger worry is whether taking your medication as prescribed leads to addiction, that is a different question, and I covered the research in is ADHD medication addictive.

Side effects: mostly the same family

Since both drugs end up as amphetamine in your body, their side effect lists overlap heavily.

For adults, the Adderall XR label lists dry mouth, loss of appetite, insomnia, headache, weight loss, nausea, anxiety, agitation, dizziness, fast heart rate, diarrhea, weakness and urinary tract infections among the most common reactions. The Vyvanse label lists, across children and adults with ADHD, decreased appetite, weight loss, insomnia, dry mouth, anxiety, irritability, dizziness, nausea, upper abdominal pain, diarrhea and vomiting.

These lists come from separate trials with different designs, so they cannot be compared line by line. Neither label claims fewer side effects than the other drug.

Appetite and sleep are the two complaints that come up most in real life. I wrote a practical piece on appetite loss on ADHD medication. For Adderall in particular, see Adderall side effects.

Is one more effective?

Not in any way the evidence can show for the average person.

The largest comparison so far, a 2018 network meta-analysis in The Lancet Psychiatry by Cortese and colleagues, pooled 133 double-blind trials. It put all amphetamines, lisdexamfetamine included, into one category. In that analysis, amphetamines were among the most effective options on clinician ratings, and the authors supported amphetamines as a preferred first choice for short-term treatment in adults. They did not separate Vyvanse from Adderall, so the study cannot tell you which of the two is better.

In practice, prescribers usually choose based on things the trials do not settle: how long your day is, whether you need flexibility, how you handle a sharper versus slower rise, your heart health, what your insurance covers and what the pharmacy actually has. If one does not suit you, trying the other is a common next step. The right fit is something you work out with your prescriber over time.

If you want the full picture of Vyvanse on its own, there is a separate guide on Vyvanse for ADHD.

Generics, cost and the shortage

For years, Vyvanse had no generic. That changed in August 2023, when the FDA approved the first generic lisdexamfetamine capsules and chewable tablets. DailyMed now lists lisdexamfetamine labels from many manufacturers. Generic mixed amphetamine salts, both immediate-release and extended-release, have been around much longer.

Supply is a separate problem. As of October 23, 2026, the FDA Drug Shortages database still lists both immediate-release mixed amphetamine salts tablets (first posted in October 2022) and lisdexamfetamine capsules and chewable tablets (first posted in July 2023) as current shortages. Availability can differ by strength, manufacturer and pharmacy. The background is in the Adderall shortage, and my own general notes on coping when a prescription runs out are in ADHD medication out of stock.

Questions to bring to your appointment

You do not need to arrive with an answer. It helps to arrive with information about your own day:

• What hours do you most need coverage: a school day, a 10 hour shift, evening study?
• Do you want one dose or the option to skip an afternoon dose?
• How is your sleep right now, and how is your appetite?
• Do you have any heart conditions, high blood pressure or a history of substance use?
• Have you had trouble swallowing capsules?
• What does your insurance plan cover, and what has your pharmacy been able to fill lately?

Writing these down before the visit makes the conversation shorter and more useful. The decision about which medication and what dose belongs with your prescriber, who can weigh your history in a way no comparison table can.

The bottom line

Vyvanse and Adderall are close relatives, not opposites. One is a prodrug that releases dextroamphetamine slowly through your blood. The other is a mix of amphetamine salts that comes in a short-acting tablet and a two-bead extended-release capsule.

The prodrug design gives Vyvanse a gradual rise and a long window, and it makes misuse harder without making it impossible. Adderall gives more ways to shape the day. Both carry the same warnings. Neither is the better drug for everyone.

If you are deciding between them, the most useful thing you can do is understand your own day well enough to describe it. The rest is a conversation, and sometimes a bit of trial and adjustment, with the person who writes the prescription.